The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

8 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Rational design of novel nucleoside analogues reveals potent antiviral agents for EV71.EBI
Swansea University
METTL3 from Target Validation to the First Small-Molecule Inhibitors: A Medicinal Chemistry Journey.EBI
Sapienza University of Rome
Roles and drug development of METTL3 (methyltransferase-like 3) in anti-tumor therapy.EBI
Yunnan University
1,4,9-Triazaspiro[5.5]undecan-2-one Derivatives as Potent and Selective METTL3 Inhibitors.EBI
University of Zurich
Novel METTL3 Modulators for Treating Acute Myeloid Leukemia (AML).EBI
Smith, Gambrell & Russell
CONDENSED HETEROCYCLIC COMPOUNDBDB
Nissan Chemical
Heterocyclic compounds as pad inhibitorsBDB
Jubilant Epipad
CDK2 inhibitorsBDB
Pfizer